SGMO | Sangamo Therapeutics Category: Biotechnology company Quick infos Headquarters: Richmond, California, United States Trade prices Volume: Market Cap: 627.82M Prev closed: Open: 6.01 High: 6.07 Low: 5.75 52 week low: 5.1 52 week high: 13.93 Dividends: No Dividends Next ER: April 26, 2023 After Market Closes
About the Company
Sangamo Therapeutics, Inc. is an American biotechnology company based in Richmond, California. It applies cell and gene therapy to combat haemophilia and other genetic diseases.
Date EPS / Forecast Revenue / Forecast August 9, 2023 April 26, 2023 - / -0.321 - / 24.19M February 22, 2023 -0.32 / -0.36 27.23M / 26.86M Beat! November 3, 2022 -0.34 / -0.3555 26.46M / 26.59M August 4, 2022 -0.29 / -0.3527 29.38M / 24.63M Beat! view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company ISIN: US8006771062 CUSIP: 800677106 Founded: 1995 Employees: 131 News Sangamo Therapeutics (NASDAQ:SGMO) investors are sitting on a loss of 78% if they invested five years ago finance.yahoo.com Dec 6, 2022 6:02 am Sangamo Therapeutics GAAP EPS of -$0.34 beats by $0.02, revenue of $26.5M misses by $0.29M seekingalpha.com Nov 4, 2022 4:02 am Sangamo Therapeutics (SGMO) Reports Q3 Loss, Lags Revenue Estimates finance.yahoo.com Nov 3, 2022 5:55 pm Sangamo Therapeutics Q3 2022 Earnings Preview seekingalpha.com Nov 3, 2022 5:35 am Sangamo Therapeutics Announces Third Quarter 2022 Conference Call and Webcast finance.yahoo.com Oct 27, 2022 4:15 pm Pfizer, Sangamo reopen recruitment for late-stage trial of hemophilia A gene therapy seekingalpha.com Sep 23, 2022 5:38 am Sangamo Touts Additional Positive Data For Fabry Gene Therapy Candidate finance.yahoo.com Oct 12, 2022 8:55 am Pfizer Resumes Dosing In Phase 3 Hemophilia Gene Therapy Trial Six Months After FDA Lifts Clinical Hold finance.yahoo.com Sep 23, 2022 12:02 pm Sangamo gene therapy for Fabry disease shows promise in phase 1/2 trial seekingalpha.com Aug 30, 2022 6:52 pm Sangamo's Fabry Disease Gene Therapy Continues To Show Encouraging Safety Profile finance.yahoo.com Aug 30, 2022 8:50 am Does Sangamo (SGMO) Have the Potential to Rally 122% as Wall Street Analysts Expect? finance.yahoo.com Aug 29, 2022 9:55 am Biotech in recovery; but Piper Sandler cites negative fund flows seekingalpha.com Aug 22, 2022 Sangamo Therapeutics GAAP EPS of -$0.29 beats by $0.06, revenue of $29.38M beats by $4.75M seekingalpha.com Aug 5, 2022 4:03 am Sangamo Therapeutics (SGMO) Reports Q2 Loss, Tops Revenue Estimates finance.yahoo.com Aug 4, 2022 5:45 pm Sangamo Therapeutics Q2 2022 Earnings Preview seekingalpha.com Aug 4, 2022 5:35 am Sangamo Therapeutics Announces Second Quarter 2022 Conference Call and Webcast finance.yahoo.com Jul 28, 2022 4:15 pm Sangamo's TX200 gets orphan drug tag in EU for use in organ transplant seekingalpha.com Jul 21, 2022 8:30 pm SGMO, IMGN and BPOP are among after hour movers seekingalpha.com Jul 20, 2022 5:25 am Is Sangamo Therapeutics (NASDAQ:SGMO) In A Good Position To Deliver On Growth Plans? finance.yahoo.com Jul 18, 2022 9:21 am Sangamo Therapeutics begun at neutral at Wedbush on 'frontrunner' Fabry candidate seekingalpha.com Jun 14, 2022 5:44 am
This company doesn't provide a dividend.
Key Persons CEO : Alexander Macrae, PhD Talk about Sangamo Therapeutics below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
If you are looking for News & events, Press Release, they are available on their Investors Relationssite. Homepage: sangamo.com
Consensus BUY 67 HOLD 33 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via
Paypal. More features coming soon :) Buy on Amazon
Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.
Take advantage of price swings in strongly trending securities and pump up your portfolio!